(Q43715704)

26 November 2017

title

PPARgamma and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and Crohn's disease (English)

1 reference

inflammatory bowel diseases

26 November 2017

1 reference

1 reference

1 reference

Wada K

1

1 reference

26 November 2017

Nakajima A

series ordinal

2

1 reference

26 November 2017

Blumberg RS

series ordinal

3

1 reference

26 November 2017

publication date

1 August 2001

1 reference

Trends in Molecular Medicine

26 November 2017

published in

1 reference

26 November 2017

volume

7

1 reference

26 November 2017

issue

8

1 reference

26 November 2017

page(s)

329-331

1 reference

Low-Dose Cyclosporine for the Treatment of Crohn's Disease

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902076-7

7 January 2021

Prospects for research in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902076-7

7 January 2021

Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902076-7

7 January 2021

Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902076-7

7 January 2021

Adipogenesis and obesity: rounding out the big picture

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902076-7

7 January 2021

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902076-7

7 January 2021

Medical significance of peroxisome proliferator-activated receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902076-7

7 January 2021

Roles of PPARs in health and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902076-7

7 January 2021

Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902076-7

7 January 2021

Activators of the nuclear receptor PPARgamma enhance colon polyp formation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902076-7

7 January 2021

Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902076-7

7 January 2021

Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCMin/+ mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902076-7

7 January 2021

Differentiation and reversal of malignant changes in colon cancer through PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902076-7

7 January 2021

PPARgamma and colorectal carcinoma: conflicts in a nuclear family

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902076-7

7 January 2021

A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902076-7

7 January 2021

Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902076-7

7 January 2021

PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902076-7

7 January 2021

The role of PPAR-gamma in macrophage differentiation and cholesterol uptake.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902076-7

7 January 2021

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902076-7

7 January 2021

Multiple signals converging on NF-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902076-7

7 January 2021

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902076-7

7 January 2021

JNK or IKK, AP-1 or NF-kappaB, which are the targets for MEK kinase 1 action?

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902076-7

7 January 2021

Cell stress and MKK6b-mediated p38 MAP kinase activation inhibit tumor necrosis factor-induced IkappaB phosphorylation and NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902076-7

7 January 2021

Tumor necrosis factor: biology and therapeutic inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902076-7

7 January 2021

Biology of inflammation in Crohn's disease: mechanisms of action of anti-TNF-a therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902076-7

7 January 2021

10.1016/S1471-4914(01)02076-7

Identifiers

DOI

1 reference

26 November 2017

1 reference